Asset Details
Do you wish to reserve the book?
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
Do you wish to request the book?
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
2022
Overview
Purpose
To evaluate the total biopsy and positive biopsy rates in women at high risk of breast cancer compared to the general population.
Methods
The study group consisted of 330 women with pathogenic variants (PVs) in
BRCA1/2
attending the dedicated multidisciplinary breast cancer clinic of a tertiary medical center in Israel. Clinical, genetic, and biopsy data were retrieved from the central healthcare database and the medical files. Patients aged 50 years or older during follow-up were matched 1:10 to women in the general population referred for routine breast cancer screening at the same age, as recommended by international guidelines. The groups were compared for rate of biopsy studies performed and percentage of positive biopsy results. Matched analysis was performed to correct for confounders.
Results
The total biopsy rate per 1000 follow-up years was 61.7 in the study group and 22.7 in the control group (
p
< 0.001). The corresponding positive biopsy rates per 1000 follow-up years were 26.4 and 2.0 (
p
< 0.001), and the positive biopsy percentages, 42.9% and 8.7% (
p
< 0.0001).
Conclusion
Women aged 50 + years with PVs in
BRCA1/2
attending a dedicated clinic have a 2.7 times higher biopsy rate per 1000 follow-up years, a 13.2 times higher positive biopsy rate per 1000 follow-up years, and a 4.9 times higher positive biopsy percentage than same-aged women in the general population.
Publisher
Springer US,Springer,Springer Nature B.V
Subject
